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Abstract
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Pentachlorophenol (PCP) is used as a wood preservative and is found in human blood and urine. PCP
causes significant decreases in the tumor-killing (lytic) function of human natural killer (NK) cells,
a critical immune defense. The current study examined the association between decreased lytic
function and decreased ATP levels, as well as the ability of antioxidants (vitamin E and reduced
glutathione) to prevent PCP-induced decreases in either ATP levels or lytic function. Exposure of
NK cells to 10μM PCP decreased ATP levels by 15% at 24 h, and exposure to 5 μM PCP decreased
ATP levels by 32% at 48 h. No effects were seen with 0.5 μM at 48 h or with 5 μM at 24 h. However,
10 μM PCP decreased lytic function by 69% at 24h and 5 μM decreased it by 90% at 48 h. Even 0.5
μM PCP decreased lytic function by 46% at 48 h. None of these effects were prevented by
pretreatment with 1 mM vitamin E or reduced glutathione.
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INTRODUCTION

NIH-PA Author Manuscript

Pentachlorophenol (PCP) was at one time registered for use as an insecticide, fungicide,
herbicide, molluscicide, algicide, disinfectant, and ingredient in antifouling paints (Cirelli
1978). Its use was restricted in 1984 (EPA, 2001). It is now mainly used as a wood preservative
for power-line poles and fence posts. Approximately 80% of the PCP used in the U.S. is for
the treatment of wooden utility poles (ATSDR, 2001). As with other organochlorine
compounds PCP is quite stable. Due to its once widespread use and chemical stability, it is a
very significant environmental contaminant. Humans are exposed to PCP through inhalation,
absorption through the skin, and consumption of contaminated food and water (ATSDR,
2001). Measurable levels of PCP have been detected in human blood and urine (Atuma and
Okor, 1985; CDC, 2005; Cline et al., 1989; Jones et al., 1986; Thornton et al., 2002; Uhl et al.
1986). Levels ranging from 0.26 −5 μM were found in the serum of individuals residing in
PCP-treated log homes (Cline et al., 1989). Levels averaging about 0.15 μM were found in the
serum of individuals with no known exposure (Cline et al., 1989; Uhl et al., 1986).
Natural Killer (NK) cells are a subset of lymphocytes that are capable of killing tumor cells,
virally infected cells and antibody-coated cells. NK cells are capable of killing tumor cells
without prior sensitization, putting them in the forefront of lymphocyte defense against tumor
cells and virally infected cells (Vivier et al., 2004; Wu and Lanier, 2003). NK cells are defined
by the absence of the T cell receptor/CD3 complex and by the presence of CD56 and/or CD16
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on the cell surface. About 95% of NK cells in human peripheral blood are CD56dim/
CD16bright and express high levels of the cytotoxic protein, perforin (Walzer et al. 2005). They
are responsible for limiting the spread of blood borne metastases, as well as limiting the
development of primary tumors (Hanna, 1980; Kiessling and Haller, 1978). NK cells also play
a central role in immune defense against viral infection as evidenced by greatly increased
incidence of viral infection seen in individuals where the NK subset of lymphocytes is
completely absent (Fleisher et al., 1982; Biron et al, 1989). Therefore, any chemical that can
affect the ability of NK cells to recognize and lyse a target cell, could potentially increase the
risk of tumors and viral infections.
In a past study we found that exposure of human NK cells to PCP decreased their lytic function.
Exposure of NK cells to as little as 0.5 μM PCP for 48 h decreased lytic function about 50%
(Reed et al., 2004). The mechanism by which PCP exposure might be interfering with NK cell
lytic function was not addressed in that study.
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In this study we examined the effects of PCP exposures on ATP levels in NK cells in order to
begin to elucidate the mechanism by which PCP decreases lytic function. This data will allow
us to determine if PCP is able to interfere with ATP production in NK cells and whether any
interference is associated with loss of NK lytic function. Additionally, we examined whether
the antioxidants, vitamin E or reduced glutathione, were able to reverse the negative effects of
PCP on lytic function and/or ATP levels, as there has been evidence in rodents (Dorsey et al.,
2006; Umemura et al., 2006; 2003) and in human hepatoma cell lines (Wang et al., 2001) and
human liver cell microsomes (Juhl et al., 1985) that PCP oxidative metabolism is important in
its toxic effects in those systems.

MATERIALS AND METHODS
Isolation of NK cells
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Peripheral blood from healthy volunteer donors (male and female adults) was used for this
study. Fresh blood bank buffy coats were collected at a Red Cross donation facility (American
Red Cross, Portland, OR). Highly purified NK cells were obtained using a rosetting procedure.
Buffy coats were mixed with 1 mL of RosetteSep™ Human NK cell enrichment antibody
cocktail (StemCell Technologies, Vancouver, British Columbia, Canada) per 30 mL of buffy
coat. The mixture was incubated for 25 min at room temperature with periodic mixing.
Following the incubation 4 mL of the mixture was layered onto 4 mL of Ficoll-Hypaque (1.077
g/mL) (Sigma), and centrifuged at 1200g for 30 min. The cell layer was collected and washed
twice with PBS and stored in complete media (RPMI-1640 supplemented with 2 mM Lglutamine, 50 U penicillin G and 50 μg streptomycin/ml) plus 10% heat-activated bovine calf
serum (BCS) at 1 million cells/mL. The resulting cell preparation was >95% CD16+, 0%
CD3+ by fluorescence microscopy (Reed et al., 2004).
Chemical Preparation
PCP was purchased from Sigma-Aldrich Chemical Company (St. Louis, MO). A stock solution
of PCP was made in DMSO. The stock was diluted in gelatin media (0.5% gelatin replaced the
calf serum in complete medium) to achieve the desired concentrations, so that the final
concentration of DMSO did not exceed 0.01%.
Cell Treatments and cell viability
NK cells were separated by centrifugation from complete medium (defined above) and
transferred to complete medium containing 0.5% gelatin in place of the 10% bovine serum.
This was done in order to avoid binding of the hydrophobic PCP to serum albumin, which
could interfere with its delivery to the cells. NK cells were then exposed to PCP for 24 h, 48
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h, or 6 days. The concentration range examined was 10 − 0.1 μM PCP depending on the length
of exposure.

NIH-PA Author Manuscript

Cell viability was determined by trypan blue exclusion. Cell numbers and viability were
assessed at the beginning and end of each exposure period. Cell numbers and their viability
did not vary significantly among experimental conditions for any of the concentrations of the
compounds used in the experiments at a given length of incubation.
Chromium Release Assay
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NK cytotoxicity was measured using a 51Cr release assay (Whalen et al., 1999; Whalen,
1997). The target cell in all cytotoxicity assays was the NK-susceptible K562 (human chronic
myelogenous leukemia) cell line. K562 cells were incubated with 51Cr in 1 ml of BCS for 1.5
hr at 37 °C in air/CO2 (19:1). Following this incubation the target cells were washed twice with
gelatin medium. NK (effector) cells (1.2×105/100 μL for 12:1 ratio) were added to the wells
of round-bottomed microwell plates. The effectors were diluted to 6:1 ratio (0.6×105/100 μL)
and 3:1 ratio (0.3×105/100 μL); each ratio was tested in triplicate. Target cells were added
(1×104/100μL) to the wells and the plate was centrifuged at 300 g for 3 min and incubated for
2 hr at 37 °C ( air/CO2 ,19:1). After incubation a 0.1 ml aliquot of the supernatant was collected
and counted for radioactivity for 60 sec in a Packard COBRA gamma radiation counter
(Packard Instrument Co., Meriden, CT). Target lysis was calculated as follows: 100×[(test
c.p.m - spontaneous c.p.m.)/maximum c.p.m.- spontaneous c.p.m.)]. Maximum release was
produced by adding 100 μL of 10% Triton X-100. Statistical analysis of the data was carried
out utilizing ANOVA and Student's t test. Data were initially compared within a given
experimental setup by ANOVA. A significant ANOVA was followed by pair wise analysis of
control versus exposed data at each NK to target ratio and each concentration using Student's
t test.
ATP assay

NIH-PA Author Manuscript

ATP levels were measured as described by Dudimah et al., 2007a,b. Following the cell
exposure to the various concentrations of PCP; 250,000 NK cells (167 μL of the cell
suspension) were removed, diluted by addition of 300 μL of PBS, and centrifuged for ninety
seconds to pellet the cells. All media was removed and the cell pellet was resuspended in 375
μL of distilled water. 150 μL of this suspension was added to 300 μL of somatic cell ATP
releasing reagent (Sigma-Aldrich). To measure ATP, 100 μL of the lysed cell suspension was
added to 100 μL of a Luciferin/Luciferase mixture. The light emission was measured using the
Kodak Imaging system (Kodak, Rochester NY). ATP levels were determined from a standard
curve. Statistical analysis of the data was carried out utilizing ANOVA and followed by
pairwise comparison using Student's t test.

RESULTS
Effects of 24 h, 48 h, and 6 d exposures to PCP on ATP levels in NK cells
Figure 1 shows the effects of 24 h, 48 h, and 6 d exposures to 0.1 to 10 μM PCP on ATP levels
in human NK cells. A 24 h exposure to 10 μM PCP caused an approximately 15% decrease in
the level of ATP in NK cells as compared to control cells (p<0.01) (Fig. 1A). After a 48 h
exposure to 5 μM PCP there was about a 32% decrease in ATP levels (p<0.01). A 48 h exposure
to both 2.5 and 1 μM PCP caused small decreases in ATP levels (12−15%, p<0.01) (Fig. 1B).
Exposure to PCP for 6 days caused decreases in ATP, at 1, 0.5 and 0.2 μM, of 67%, 35%, and
20% respectively (p<0.01) (Fig. 1C). The highest concentration used at any given time point
did not affect NK cell viability.
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Comparison of the effects of PCP on lytic function and ATP levels in NK cells
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Although previous studies have shown decreased lytic function with PCP exposures (Reed et
al., 2004), it was important to carry out studies of lytic function in parallel with those
determining ATP levels. This will allow a valid comparison of these two parameters using cells
prepared on the same day. The decreases in ATP at these same concentrations of PCP were
plotted on the same graph to aid in seeing the extent of association between the two parameters.
Figure 1 shows the results of studies examining the lytic function of NK cells exposed to 0.5
μM to 10 μM PCP for 24 h, 48 h and 6 d. A 24 h exposure to PCP caused significant decreases
in lytic function at all concentrations (Fig. 1A). The decreases were 15%, 31%, 42%, 45%, and
69% at 0.5, 1, 2.5, 5, and 10 μM PCP, respectively (p<0.01).
Figure 1B shows the lytic function plotted along with ATP levels of NK cells exposed to 0.5
− 5 μM PCP for 48 h. Lytic function was decreased very significantly at all concentrations of
PCP tested. Decreases were 46, 70, 83 and 90 % at 0.5, 1, 2.5 and 5 μM, respectively (p<0.001).
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The lytic function of NK cells exposed to 0.2−1 μM PCP for 6 days is shown in Figure 1C.
Cells exposed to 0.2 μM PCP showed no significant decrease in lytic function (p>0.05).
However, cells exposed to either 0.5 and 1 μM PCP showed very large decreases in lytic
function. The decrease in lytic function was 73% (p<0.0001) in cells exposed to 0.5 μM PCP
and 88% (p<0.0001) in those exposed to 1 μM PCP.
Effects of vitamin E and reduced glutathione on the PCP-induced decreases in ATP
The antioxidant vitamin E was tested for its ability to prevent the deleterious affects of PCP
on ATP levels in NK cells. NK cells were pre-incubated with 1 mM vitamin E for 1 h prior to
the addition of PCP. The 1 mM vitamin E remained for the duration of the exposures to PCP.
Figure 2 shows that when NK cell were exposed to 10 μM PCP for 24 h that the decrease in
ATP levels of about 15% was not statistically changed by the presence of 1 mM vitamin E.
Additionally, vitamin E was ineffective in preventing the approximately 32% decrease in ATP
caused by a 48 h exposure to 5 μM PCP.
NK cells were also pre-incubated with 1 mM reduced glutathione (GSH) for 1 h prior to the
addition of PCP, which remained for the duration of the exposures to PCP. Figure 2 shows that
the presence of GSH did not diminish the decreases in ATP induced by PCP. The effect of
PCP was in fact somewhat greater when GSH was present than in its absence (P<0.05).
Effects of vitamin E and reduced glutathione on the PCP induced decreases in lytic function
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As seen in Figure 1 loss of lytic function by NK cells occurs prior to any decreases in ATP
levels. Thus, we examined whether the antioxidants vitamin E or reduced glutathione might
be able to prevent the loss of lytic function. NK cells were pre-incubated for 1 h prior to
exposure to PCP with either 1 mM vitamin E or 1 mM reduced glutathione, which remained
throughout the exposure to PCP. Figure 3 shows the results of studies examining 24 h exposure
of NK cells to PCP concentrations from 0.5 − 5 μM plus and minus 1 mM vitamin E or 1 mM
glutathione. There was no difference in effectiveness of the PCP to decrease NK lytic function
whether or not the antioxidant was present at any of the PCP concentrations tested.
Vitamin E was also tested for its ability to prevent PCP-induced loss of lytic function after a
48 h or 6 d exposure PCP. As was seen after a 24 h exposure there was no change in the
effectiveness of any concentration of PCP when vitamin E was present in the incubation (data
not shown).
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Our previous studies demonstrated that PCP was capable of interfering with the function of
human NK cells (Reed et al., 2004). This PCP-induced decrease in NK function may play a
role in the development of cancers that are associated with PCP exposures (Demers et al.,
2006). It has been shown that PCP (∼20 μM) can block oxidative phosphorylation in rat liver
(Weinbach, 1954; Weinbach and Garbus, 1965), which would lead to decreases in ATP levels.
In this study we found that exposure to PCP can decrease ATP levels in NK cells at higher
concentrations and longer exposures (6 days). However, PCP decreased the lytic function of
NK cells at concentrations that were lower than those that decreased ATP levels at 24 or 48 h
of exposure. These results suggest that decreases in intracellular ATP levels are not an
underlying cause of the losses of lytic function that are seen when NK cells are exposed to PCP
for 24 h or 48 h.
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A number of previous studies have shown that oxidative metabolites of PCP are responsible
for some of its toxic effects in rodents (Dorsey et al., 2006; Umemura et al., 2006; 2003; Wang
et al., 2001). Additionally, PCP has effects similar to butyltin (BT) compounds on NK lytic
function and ATP levels (Whalen et al. 1999; Dudimah et al 2007a,b) and glutathione and other
sulfhydryl containing compounds have been shown to reverse the negative effects of BT
compounds on ATP (Cain et al., 1977). Thus, we examined the ability of the antioxidants,
reduced glutathione and vitamin E, to ameliorate the negative effects of PCP exposures on NK
lytic function and ATP levels. We found that neither of the antioxidants was able to prevent
the decreases in lytic function or ATP levels seen when NK cells were exposed to PCP. This
indicated that the oxidative metabolism of PCP does not significantly contribute to its toxic
effects in human NK cells.
In summary these studies indicate that : 1.) ATP levels in NK cells are decreased by certain
PCP exposures 2.) loss of NK lytic function seen with PCP exposure is not primarily due to
decreases in ATP levels; 3.) losses of lytic function and decreases in ATP seen with PCP
exposures do not appear to be the result of generation of reactive oxygen species or of the
oxidative metabolism of PCP in the NK cell.
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Figure 1.
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Effects of exposures to Pentacholophenol (PCP) on ATP levels (▲) and lytic function (■)
plotted on the same graph: A). 24 h exposure to PCP; B). 48 h exposure to PCP; and C). 6 day
exposure to PCP. Levels of ATP in PCP exposed cells were determined as the percentage of
ATP levels of the control cells. To combine results from separate experiments, the levels of
lysis were normalized as percentage of the lytic function of the control cells in a given
experiment. Results were the average ± S.D. of 9 or more determinations.
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Figure 2.

Effects of a 1 h pre-incubation with 1 mM vitamin E or 1 mM reduced glutathione on the
capacity of PCP to decrease ATP levels in NK cells. ATP levels were determined in NK cells
that were pre-incubated with 1 mM Vitamin E (VE), 1 mM reduced glutathione (GSH) or
control for 1 h prior to a 24 h exposure to 10 μM PCP or a 48 h exposure to 5 μM PCP. Results
were the average ± S.D. of 9 or more determinations
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Figure 3.

Effects of a 1 h pre-incubation with 1 mM vitamin E or 1 mM reduced glutathione on the
capacity of PCP to decrease the lytic function of NK cells. Lytic function was determined for
NK cells that were pre-incubated with 1 mM Vitamin E (VE); 1 mM reduced glutathione
(GSH), or control for 1 h prior to a 24 h exposure to 5−0.5 μM PCP. Results were the average
± S.D. of 6 or more determinations
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